MedTrace Logo

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

NCT03413137 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2018-01-30

No results posted yet for this study

Summary

This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy

Conditions

  • Prostate Biopsy

Interventions

PROCEDURE

Transperineal mpMRI-US Fusion prostate biopsy

mpMRI-US Fusion prostate biopsy in a transperineal approach to direct the needles towards an area in the prostate that was found as suspicious of malignancy by previous MRI imaging, defined as region of interest (ROI).

PROCEDURE

Transrectal mpMRI-US Fusion prostate biopsy

using the same system and MRI imaging, a transrectal approach would be used to sample a few more cores from the ROI as defined by the MRI imaging.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • David Margel, MD PhD · Rabn Medical Center, Beilinson Campus

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-11
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413137 on ClinicalTrials.gov